HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.

Abstract
Establishing the Amsterdam criteria, based on pedigrees, was essential for defining hereditary nonpolyposis colorectal cancer (HNPCC) syndrome in such a way that the underlying genetic cause could be identified. It is now known that about half of families that fulfill the original Amsterdam criteria have a hereditary DNA mismatch repair (MMR) gene mutation. These families may be said to have Lynch syndrome. The other half of families with HNPCC has no evidence of DNA MMR deficiency, and studies show that these families are different from families with Lynch syndrome. Familial colorectal cancer type X is the name used to refer to the "other half of HNPCC".
AuthorsNoralane M Lindor
JournalSurgical oncology clinics of North America (Surg Oncol Clin N Am) Vol. 18 Issue 4 Pg. 637-45 (Oct 2009) ISSN: 1558-5042 [Electronic] United States
PMID19793571 (Publication Type: Journal Article, Review)
Chemical References
  • Neoplasm Proteins
Topics
  • Colorectal Neoplasms, Hereditary Nonpolyposis (classification, genetics)
  • DNA Mismatch Repair (genetics)
  • Humans
  • Neoplasm Proteins (genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: